Notice: This company has been marked as potentially delisted and may not be actively trading. TF Financial (THRD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends THRD vs. MIRM, CNTA, SUPN, MNKD, HRMY, IRON, EVO, NAMS, GPCR, and ARVNShould you be buying TF Financial stock or one of its competitors? The main competitors of TF Financial include Mirum Pharmaceuticals (MIRM), Centessa Pharmaceuticals (CNTA), Supernus Pharmaceuticals (SUPN), MannKind (MNKD), Harmony Biosciences (HRMY), Disc Medicine (IRON), Evotec (EVO), NewAmsterdam Pharma (NAMS), Structure Therapeutics (GPCR), and Arvinas (ARVN). These companies are all part of the "pharmaceutical preparations" industry. TF Financial vs. Mirum Pharmaceuticals Centessa Pharmaceuticals Supernus Pharmaceuticals MannKind Harmony Biosciences Disc Medicine Evotec NewAmsterdam Pharma Structure Therapeutics Arvinas TF Financial (NASDAQ:THRD) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, community ranking, analyst recommendations, media sentiment and institutional ownership. Does the media refer more to THRD or MIRM? In the previous week, Mirum Pharmaceuticals had 30 more articles in the media than TF Financial. MarketBeat recorded 30 mentions for Mirum Pharmaceuticals and 0 mentions for TF Financial. Mirum Pharmaceuticals' average media sentiment score of 0.65 beat TF Financial's score of 0.00 indicating that Mirum Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment TF Financial Neutral Mirum Pharmaceuticals Positive Which has more volatility & risk, THRD or MIRM? TF Financial has a beta of 2.84, meaning that its share price is 184% more volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Is THRD or MIRM more profitable? TF Financial has a net margin of 0.00% compared to Mirum Pharmaceuticals' net margin of -31.69%. TF Financial's return on equity of -9.31% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TF FinancialN/A -9.31% -9.03% Mirum Pharmaceuticals -31.69%-41.22%-14.81% Do analysts prefer THRD or MIRM? TF Financial presently has a consensus target price of $20.33, indicating a potential upside of 74.99%. Mirum Pharmaceuticals has a consensus target price of $57.73, indicating a potential upside of 32.52%. Given TF Financial's higher probable upside, research analysts plainly believe TF Financial is more favorable than Mirum Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TF Financial 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 3.17 Do institutionals & insiders hold more shares of THRD or MIRM? 94.0% of TF Financial shares are owned by institutional investors. 5.9% of TF Financial shares are owned by company insiders. Comparatively, 22.9% of Mirum Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable earnings and valuation, THRD or MIRM? TF Financial has higher earnings, but lower revenue than Mirum Pharmaceuticals. Mirum Pharmaceuticals is trading at a lower price-to-earnings ratio than TF Financial, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTF FinancialN/AN/A-$30.82M-$0.62-18.74Mirum Pharmaceuticals$186.37M11.22-$163.41M-$2.02-21.56 Does the MarketBeat Community favor THRD or MIRM? Mirum Pharmaceuticals received 69 more outperform votes than TF Financial when rated by MarketBeat users. Likewise, 75.58% of users gave Mirum Pharmaceuticals an outperform vote while only 67.78% of users gave TF Financial an outperform vote. CompanyUnderperformOutperformTF FinancialOutperform Votes6167.78% Underperform Votes2932.22% Mirum PharmaceuticalsOutperform Votes13075.58% Underperform Votes4224.42% SummaryTF Financial and Mirum Pharmaceuticals tied by winning 9 of the 18 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get TF Financial News Delivered to You Automatically Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRD vs. The Competition Export to ExcelMetricTF FinancialPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$523.60M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-18.745.5695.6214.22Price / SalesN/A371.591,217.1988.42Price / CashN/A52.5939.5936.27Price / Book1.7810.236.946.37Net Income-$30.82M$153.22M$118.89M$225.56M TF Financial Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRDTF Financial1.2337 of 5 stars$11.62-6.7%$20.33+75.0%+72.1%$523.60MN/A-18.74N/AMIRMMirum Pharmaceuticals4.312 of 5 stars$43.56-0.3%$57.73+32.5%+36.1%$2.09B$186.37M-21.76140Analyst RevisionCNTACentessa Pharmaceuticals4.0687 of 5 stars$17.83+6.5%$25.83+44.9%+144.7%$2.02B$6.85M-11.7172SUPNSupernus Pharmaceuticals2.3422 of 5 stars$35.88-0.7%$36.00+0.3%+32.3%$1.98B$607.52M33.76580Positive NewsMNKDMannKind3.47 of 5 stars$6.87-0.1%$8.67+26.2%+83.0%$1.89B$198.96M98.29400Insider TradeHRMYHarmony Biosciences4.7588 of 5 stars$33.12+1.0%$47.00+41.9%+18.1%$1.89B$582.02M15.64200IRONDisc Medicine3.1771 of 5 stars$63.36+1.3%$85.80+35.4%+22.4%$1.88BN/A0.0078Insider TradeAnalyst RevisionEVOEvotec1.9387 of 5 stars$5.30flat$5.93+11.9%-49.7%$1.88B$845.74M0.005,061NAMSNewAmsterdam Pharma2.9471 of 5 stars$20.21+1.0%$33.80+67.2%+110.6%$1.87B$14.09M0.0057Analyst ForecastInsider TradeNews CoverageHigh Trading VolumeGPCRStructure Therapeutics2.3011 of 5 stars$30.93-5.4%$86.80+180.6%-38.8%$1.77BN/A-42.13136Analyst RevisionARVNArvinas3.0931 of 5 stars$24.97+10.0%$61.08+144.6%+4.2%$1.72B$78.50M-5.21445Analyst ForecastShort Interest ↓News Coverage Related Companies and Tools Related Companies Mirum Pharmaceuticals Competitors Centessa Pharmaceuticals Competitors Supernus Pharmaceuticals Competitors MannKind Competitors Harmony Biosciences Competitors Disc Medicine Competitors Evotec Competitors NewAmsterdam Pharma Competitors Structure Therapeutics Competitors Arvinas Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:THRD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TF Financial Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share TF Financial With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THRD Stock Alerts